BPCR — Biopharma Credit Share Price

0.000.00%
gb flag iconLast trade - 00:00
FinancialsConservativeMid CapSuper Stock

Momentum

Relative Strength (%)
1m+5.19%
3m+2.18%
6m-2.67%
1yr-8.7%
Volume Change (%)
10d/3m-51.74%
Price vs... (%)
52w High-1.2%
50d MA+2%
200d MA+1.6%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value0.99
Price to Tang. Book0.99
Price to Free Cashflow24.04
Price to Sales11.94
EV to EBITDA13.28

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital6.78%
Return on Equity6.77%
Operating Margin81.82%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for BPCR

Brokers bullish on Biopharma Credit shares background image

Brokers bullish on Biopharma Credit shares

The Biopharma Credit (LON:BPCR) share price has risen by 1.04% over the past month and it’s currently trading at 0.97. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will co...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202131st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2021 / 2022

Blurred out image of Biopharma Credit EPS forecast chart

Profile Summary

BioPharma Credit PLC is a closed-ended investment company. The principal activity of the Company is to invest in interest-bearing-debt assets with a contractual right to future cash flows derived from royalties or sales of approved life sciences products. The Company's investment objective is to generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve its investment objectives through direct or indirect exposure to debt assets. The Company's wholly owned subsidiaries include BPCR Ongdapa Ltd. and BPCR Limited Partnership. The Company's investment manager is Pharmakon Advisors L.P.

Directors

Last Annual
December 31st, 2020
Last Interim
June 30th, 2021
Incorporated
October 24th, 2016
Public Since
March 27th, 2017
No. of Employees
0
Sector
Collective Investments
Industry
Financials
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
1,373,872,373

BPCR Share Price Performance

Latest News for BPCR

Upcoming Events for BPCR

Full Year 2021 BioPharma Credit PLC Earnings Release

BioPharma Credit PLC Annual Shareholders Meeting

Similar to BPCR

FAQ

Or unlock with your email

Or unlock with your email